Related references
Note: Only part of the references are listed.Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal Cancer
Mitsuaki Ishioka et al.
DISEASES OF THE COLON & RECTUM (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
The efficacy and safety of adding bevacizumab in neoadjuvant therapy for locally advanced rectal cancer patients: A systematic review and meta-analysis
Yue Zhou et al.
TRANSLATIONAL ONCOLOGY (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
Total Neoadjuvant Therapy in Rectal Cancer A Systematic Review and Meta-analysis of Treatment Outcomes
Fausto Petrelli et al.
ANNALS OF SURGERY (2020)
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Organ Preservation in Rectal Cancer
Jonathan B. Yuval et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer
Tsuyoshi Konishi et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma The GEMCAD 1402 Randomized Clinical Trial
Carlos Fernandez-Martos et al.
JAMA ONCOLOGY (2019)
Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting
Regina G. H. Beets-Tan et al.
EUROPEAN RADIOLOGY (2018)
Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy
Akiko Chino et al.
EJSO (2018)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta-analysis
Xi Zhong et al.
CANCER MEDICINE (2018)
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek et al.
JAMA ONCOLOGY (2018)
Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer
Carlos Carvalho et al.
LANCET ONCOLOGY (2017)
Patient-Centered Outcomes to Decide Treatment Strategy for Patients With Low Rectal Cancer
Michitaka Honda et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
Andrew G. Renehan et al.
LANCET ONCOLOGY (2016)
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment
Monique Maas et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
J. Joshua Smith et al.
BMC CANCER (2015)
Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial
Jian Xiao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
Anne J. Breugom et al.
LANCET ONCOLOGY (2015)
Mortality After Common Rectal Surgery in Japan: A Study on Low Anterior Resection From a Newly Established Nationwide Large-Scale Clinical Database
Nagahide Matsubara et al.
DISEASES OF THE COLON & RECTUM (2014)
Low Anterior Resection Syndrome Score Development and Validation of a Symptom-Based Scoring System for Bowel Dysfunction After Low Anterior Resection for Rectal Cancer
Katrine J. Emmertsen et al.
ANNALS OF SURGERY (2012)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
R. N. Whistance et al.
EUROPEAN JOURNAL OF CANCER (2009)
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results
A Habr-Gama et al.
ANNALS OF SURGERY (2004)
Share Paper
